---
title: 'Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants:
  Follow-Up of the OPTIMIST-A Randomized Clinical Trial'
date: '2023-09-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37695601/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230911181219&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS AND RELEVANCE: In this follow-up study of a randomized clinical
  trial of preterm infants with respiratory distress syndrome supported with CPAP,
  MIST compared with sham treatment did not reduce the incidence of death or NDD by
  2 years of age. However, infants who received MIST had lower rates of adverse respiratory
  outcomes during their first 2 years of ...'
disable_comments: true
---
CONCLUSIONS AND RELEVANCE: In this follow-up study of a randomized clinical trial of preterm infants with respiratory distress syndrome supported with CPAP, MIST compared with sham treatment did not reduce the incidence of death or NDD by 2 years of age. However, infants who received MIST had lower rates of adverse respiratory outcomes during their first 2 years of ...